Literature DB >> 2149685

Blood hyperviscosity and its relationship to progressive renal failure in patients with diabetic nephropathy.

M P Gordge1, A Patel, R W Faint, P B Rylance, G H Neild.   

Abstract

Blood rheology was investigated in patients with diabetic nephropathy and progressive renal insufficiency, and compared with similar non-diabetic patients and healthy control subjects. Plasma viscosity and whole blood viscosity at standardized haematocrit were elevated to a comparable degree in the two patient groups, but erythrocyte deformability was normal. In diabetic patients, the rate of progression of renal failure showed weak, but significant, correlations with plasma viscosity (rs = 0.50, p = 0.005), standardized whole blood viscosity (rs = 0.41, p = 0.021), plasma fibrinogen (rs = 0.46, p = 0.010), C reactive protein (rs = 0.40, p = 0.023), and proteinuria (rs = 0.52, p = 0.003). Both plasma viscosity and plasma fibrinogen correlated significantly with proteinuria (rs = 0.45, p = 0.012 and 0.40, p = 0.027, respectively). Rheological abnormality is probably a manifestation of increased acute phase proteins, but it remains to be determined whether these are the cause or the effect of the renal injury. Abnormal blood rheology may be a risk factor for the progression of renal failure in diabetic nephropathy.

Entities:  

Mesh:

Year:  1990        PMID: 2149685     DOI: 10.1111/j.1464-5491.1990.tb01323.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  5 in total

1.  [Cardiovascular risk factors in diabetic nephropathy].

Authors:  J Zimmermann; L Schramm; E Mulzer; E Heidbreder; H A Henrich; C Wanner
Journal:  Med Klin (Munich)       Date:  1997-02-15

Review 2.  [Thrombocytopathy and blood complications in uremia].

Authors:  Walter H Hörl
Journal:  Wien Klin Wochenschr       Date:  2006-04       Impact factor: 1.704

3.  Attenuation of Diabetic Nephropathy in Otsuka Long-Evans Tokushima Fatty (OLETF) Rats with a Combination of Chinese Herbs (Tangshen Formula).

Authors:  Haojun Zhang; Ping Li; Frank J Burczynski; Yuewen Gong; Patrick Choy; Hong Sha; Jing Li
Journal:  Evid Based Complement Alternat Med       Date:  2011-01-17       Impact factor: 2.629

4.  Therapeutic effects of calcium dobesilate on diabetic nephropathy mediated through reduction of expression of PAI-1.

Authors:  Xiaoqian Zhang
Journal:  Exp Ther Med       Date:  2012-10-19       Impact factor: 2.447

Review 5.  Acute phase reactants as novel predictors of cardiovascular disease.

Authors:  M S Ahmed; A B Jadhav; A Hassan; Qing H Meng
Journal:  ISRN Inflamm       Date:  2012-05-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.